0001140361-20-027527.txt : 20201207 0001140361-20-027527.hdr.sgml : 20201207 20201207171302 ACCESSION NUMBER: 0001140361-20-027527 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20201203 FILED AS OF DATE: 20201207 DATE AS OF CHANGE: 20201207 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Advent Partners GPE VII 2014 Limited Partnership CENTRAL INDEX KEY: 0001616578 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 201373443 BUSINESS ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 800 BOYLSTON STREET, SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 617 951-9400 MAIL ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 800 BOYLSTON STREET, SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Advent Partners GPE VII Limited Partnership CENTRAL INDEX KEY: 0001556190 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 201373444 BUSINESS ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 75 STATE STREET CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 617-951-9400 MAIL ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 75 STATE STREET CITY: BOSTON STATE: MA ZIP: 02109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ADVENT INTERNATIONAL CORP/MA CENTRAL INDEX KEY: 0001034196 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 201373445 BUSINESS ADDRESS: STREET 1: 800 BOYLSTON STREET SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 6179510555 MAIL ADDRESS: STREET 1: 800 BOYLSTON STREET SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Advent Partners GPE VII-A 2014 Cayman Limited Partnership CENTRAL INDEX KEY: 0001616564 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 201373446 BUSINESS ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 800 BOYLSTON STREET SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 617-951-9493 MAIL ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 800 BOYLSTON STREET SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Advent Partners GPE VII-A Limited Partnership CENTRAL INDEX KEY: 0001559259 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 201373447 BUSINESS ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 75 STATE STREET CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 617-951-9400 MAIL ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 75 STATE STREET CITY: BOSTON STATE: MA ZIP: 02109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Advent Partners GPE VII-A Cayman Limited Partnership CENTRAL INDEX KEY: 0001559260 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 201373448 BUSINESS ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 75 STATE STREET CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 617-951-9400 MAIL ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 75 STATE STREET CITY: BOSTON STATE: MA ZIP: 02109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Advent Partners GPE VIII-B Cayman Limited Partnership CENTRAL INDEX KEY: 0001677005 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 201373449 BUSINESS ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 800 BOYLSTON STREET SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 617-951-9400 MAIL ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 800 BOYLSTON STREET SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Advent Partners GPE VII 2014 Cayman Limited Partnership CENTRAL INDEX KEY: 0001616563 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 201373450 BUSINESS ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 800 BOYLSTON STREET, SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 617-951-9493 MAIL ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 800 BOYLSTON STREET, SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Advent Partners GPE VII Cayman Limited Partnership CENTRAL INDEX KEY: 0001561808 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 201373451 BUSINESS ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 75 STATE STREET CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 617-951-9400 MAIL ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 75 STATE STREET CITY: BOSTON STATE: MA ZIP: 02109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Advent Partners GPE VII-A 2014 Limited Partnership CENTRAL INDEX KEY: 0001616577 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 201373452 BUSINESS ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 800 BOYLSTON STREET, SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 617-951-9493 MAIL ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 800 BOYLSTON STREET, SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Syneos Health, Inc. CENTRAL INDEX KEY: 0001610950 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 273403111 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1030 SYNC STREET CITY: MORRISVILLE STATE: NC ZIP: 27560 BUSINESS PHONE: 919-876-9300 MAIL ADDRESS: STREET 1: 1030 SYNC STREET CITY: MORRISVILLE STATE: NC ZIP: 27560 FORMER COMPANY: FORMER CONFORMED NAME: INC Research Holdings, Inc. DATE OF NAME CHANGE: 20140616 4 1 form4.xml FORM 4 X0306 4 2020-12-03 0001610950 Syneos Health, Inc. SYNH 0001034196 ADVENT INTERNATIONAL CORP/MA PRUDENTIAL TOWER, 800 BOYLSTON STREET SUITE 3300 BOSTON MA 02199-8069 true 0001556190 Advent Partners GPE VII Limited Partnership C/O ADVENT INTERNATIONAL CORPORATION 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true 0001616578 Advent Partners GPE VII 2014 Limited Partnership C/O ADVENT INTERNATIONAL CORPORATION 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true 0001616577 Advent Partners GPE VII-A 2014 Limited Partnership C/O ADVENT INTERNATIONAL CORPORATION 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true 0001561808 Advent Partners GPE VII Cayman Limited Partnership C/O ADVENT INTERNATIONAL CORPORATION 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true 0001616563 Advent Partners GPE VII 2014 Cayman Limited Partnership C/O ADVENT INTERNATIONAL CORPORATION 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true 0001677005 Advent Partners GPE VIII-B Cayman Limited Partnership C/O ADVENT INTERNATIONAL CORPORATION 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true 0001559260 Advent Partners GPE VII-A Cayman Limited Partnership C/O ADVENT INTERNATIONAL CORPORATION 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true 0001559259 Advent Partners GPE VII-A Limited Partnership C/O ADVENT INTERNATIONAL CORPORATION 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true 0001616564 Advent Partners GPE VII-A 2014 Cayman Limited Partnership C/O ADVENT INTERNATIONAL CORPORATION 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true Class A Common Stock 2020-12-03 4 S 0 3228241 61.28 D 15418795 I See Notes See Exhibit 99.1 for text of footnote (1). See Exhibit 99.1 for text of footnote (2). See Exhibit 99.1 for text of footnote (3). See Exhibit 99.1 for text of footnote (4). Exhibit 99.1 (Footnotes to Form 4) and Exhibit 99.2 (Signatures and Joint Filer Information) are incorporated herein by reference. This Form 4 is the third of six Form 4s being filed relating to the same event. This Form 4 has been split into six filings because there are more than 10 Reporting Persons in total, and the SEC's EDGAR filing system limits a single Form 4 to a maximum of 10. Each part will be filed by Designated Filer, Advent International Corporation. See Exhibit 99.2 2020-12-07 EX-99.1 2 brhc10017660_ex99-1.htm EXHIBIT 99.1

Exhibit 99.1

Name and Address of Reporting Person:
Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
Date of Earliest Transaction Required to be Reported:
December 3, 2020
(Month/Day/Year)

Footnotes to Form 4
(1) Represents shares of Class A Common Stock (“Common Stock”) of Syneos Health, Inc. (the “Issuer”) sold in connection with a secondary offering of the Issuer’s Common Stock by the following entities: 55,164 shares sold by Advent International GPE VIII-C Limited Partnership (“GPE VIII-C”) and 3,173,077 shares sold by Double Eagle Investor Holdings, L.P. (“Double Eagle Investor Holdings”), of which: 659 shares were indirectly sold by Advent Partners GPE VII Limited Partnership, 1,685 shares were indirectly sold by Advent Partners GPE VII 2014 Limited Partnership, 1,556 shares were indirectly sold by Advent Partners GPE VII-A Limited Partnership, 4,620 shares were indirectly sold by Advent Partners GPE VII-A 2014 Limited Partnership, 11,221 shares were indirectly sold by Advent Partners GPE VII (Cayman) Limited Partnership, 3,793 shares were indirectly sold by Advent Partners GPE VII 2014 Cayman Limited Partnership, 2,967 shares were indirectly sold by Advent Partners GPE VII-A (Cayman) Limited Partnership, 15,383 shares were indirectly sold by Advent Partners GPE VII-B (Cayman) Limited Partnership, 2,676 shares were indirectly sold by Advent Partners GPE VII-A 2014 (Cayman) Limited Partnership (collectively, the “Advent Partners GPE VII Funds”); 140,487 shares were indirectly sold by Advent International GPE VII-A Limited Partnership, 311,693 shares were indirectly sold by Advent International GPE VII-E Limited Partnership, 24,364 shares were indirectly sold by Advent International GPE VII-H Limited Partnership (collectively, the “GPE VII GP Funds”); 151,782 shares were indirectly sold by Advent International GPE VII Limited Partnership, 432,718 shares were indirectly sold by Advent International GPE VII-B Limited Partnership, 137,514 shares were indirectly sold by Advent International GPE VII-C Limited Partnership, 90,875 shares were indirectly sold by Advent International GPE VII-D Limited Partnership, 40,127 shares were indirectly sold by Advent International GPE VII-F Limited Partnership, 40,127 shares were indirectly sold by Advent International GPE VII-G Limited Partnership (collectively, the “GPE VII GP S.a.r.l. Funds”); 102,258 shares were indirectly sold by Advent International GPE VIII Limited Partnership, 338,720 shares were indirectly sold by Advent International GPE VIII-B Limited Partnership, 120,194 shares were indirectly sold by Advent International GPE VIII-B-1 Limited Partnership, 89,616 shares were indirectly sold by Advent International GPE VIII-B-2 Limited Partnership, 139,938 shares were indirectly sold by Advent International GPE VIII-B-3 Limited Partnership, 47,178 shares were indirectly sold by Advent International GPE VIII-D Limited Partnership, 13,981 shares were indirectly sold by Advent International GPE VIII-F Limited Partnership, 123,864 shares were indirectly sold by Advent International GPE VIII-H Limited Partnership, 115,180 shares were indirectly sold by Advent International GPE VIII-I Limited Partnership, 113,189 shares were indirectly sold by Advent International GPE VIII-J Limited Partnership (collectively, the “GPE VIII GP S.a.r.l. Funds”); 239,858 shares were indirectly sold by Advent International GPE VIII-A Limited Partnership, 52,543 shares were indirectly sold by Advent International GPE VIII-E Limited Partnership, 89,116 shares were indirectly sold by Advent International GPE VIII-G Limited Partnership, 49,043 shares were indirectly sold by Advent International GPE VIII-K Limited Partnership, 48,265 shares were indirectly sold by Advent International GPE VIII-L Limited Partnership (collectively, the “GPE VIII GP Funds”); 23,566 shares were indirectly sold by Advent Partners GPE VIII Cayman Limited Partnership, 3,138 shares were indirectly sold by Advent Partners GPE VIII-A Cayman Limited Partnership, 40,318 shares were indirectly sold by Advent Partners GPE VIII-B Cayman Limited Partnership, 3,955 shares were indirectly sold by Advent Partners GPE VIII Limited Partnership, and 4,910 shares were indirectly sold by Advent Partners GPE VIII-A Limited Partnership (collectively, the “Advent Partners GPE VIII Funds”).

Page 1 of 2

(2) Following the offering, Advent manages funds that collectively own 15,418,795 shares, which are represented as follows: 263,478 shares held directly by GPE VIII-C and 15,155,317 shares held directly by Double Eagle Investor Holdings, of which: 3,145 shares are indirectly owned by Advent Partners GPE VII Limited Partnership, 8,050 shares are indirectly owned by Advent Partners GPE VII 2014 Limited Partnership, 7,432 shares are indirectly owned by Advent Partners GPE VII-A Limited Partnership, 22,064 shares are indirectly owned by Advent Partners GPE VII-A 2014 Limited Partnership, 53,595 shares are indirectly owned by Advent Partners GPE VII (Cayman) Limited Partnership, 18,118 shares are indirectly owned by Advent Partners GPE VII 2014 Cayman Limited Partnership, 14,169 shares are indirectly owned by Advent Partners GPE VII-A (Cayman) Limited Partnership, 73,470 shares are indirectly owned by Advent Partners GPE VII-B (Cayman) Limited Partnership, 12,784 shares are indirectly owned by Advent Partners GPE VII-A 2014 (Cayman) Limited Partnership; 670,995 shares are indirectly owned by Advent International GPE VII-A Limited Partnership, 1,488,715 shares are indirectly owned by Advent International GPE VII-E Limited Partnership, 116,365 shares are indirectly owned by Advent International GPE VII-H Limited Partnership; 724,946 shares are indirectly owned by Advent International GPE VII Limited Partnership, 2,066,765 shares are indirectly owned by Advent International GPE VII-B Limited Partnership, 656,795 shares are indirectly owned by Advent International GPE VII-C Limited Partnership, 434,038 shares are indirectly owned by Advent International GPE VII-D Limited Partnership, 191,655 shares are indirectly owned by Advent International GPE VII-F Limited Partnership, 191,655 shares are indirectly owned by Advent International GPE VII-G Limited Partnership; 488,406 shares are indirectly owned by Advent International GPE VIII Limited Partnership, 1,617,801 shares are indirectly owned by Advent International GPE VIII-B Limited Partnership, 574,074 shares are indirectly owned by Advent International GPE VIII-B-1 Limited Partnership, 428,026 shares are indirectly owned by Advent International GPE VIII-B-2 Limited Partnership, 668,374 shares are indirectly owned by Advent International GPE VIII-B-3 Limited Partnership, 225,330 shares are indirectly owned by Advent International GPE VIII-D Limited Partnership, 66,779 shares are indirectly owned by Advent International GPE VIII-F Limited Partnership, 591,604 shares are indirectly owned by Advent International GPE VIII-H Limited Partnership, 550,128 shares are indirectly owned by Advent International GPE VIII-I Limited Partnership, 540,614 shares are indirectly owned by Advent International GPE VIII-J Limited Partnership; 1,145,617 shares are indirectly owned by Advent International GPE VIII-A Limited Partnership, 250,956 shares are indirectly owned by Advent International GPE VIII-E Limited Partnership, 425,635 shares are indirectly owned by Advent International GPE VIII-G Limited Partnership, 234,243 shares are indirectly owned by Advent International GPE VIII-K Limited Partnership, 230,526 shares are indirectly owned by Advent International GPE VIII-L Limited Partnership; 112,557 shares are indirectly owned by Advent Partners GPE VIII Cayman Limited Partnership, 14,986 shares are indirectly owned by Advent Partners GPE VIII-A Cayman Limited Partnership, 192,565 shares are indirectly owned by Advent Partners GPE VIII-B Cayman Limited Partnership, 18,888 shares are indirectly owned by Advent Partners GPE VIII Limited Partnership, and 23,452 shares are indirectly owned by Advent Partners GPE VIII-A Limited Partnership.

(3) Advent is the Sole Member of Double Eagle GP, LLC, which in turn is the General Partner of Double Eagle Investor Holdings. Advent is the Manager of Advent International GPE VII, LLC (“GPE VII LLC”) and Advent International GPE VIII, LLC (“GPE VIII LLC”).

GPE VII, LLC is the General Partner of GPE VII GP S.a.r.l. (“GPE VII GP S.a.r.l.”), GPE VII GP Limited Partnership (“GPE VII GP”), and the Advent Partners GPE VII Funds. GPE VII GP is the General Partner of the GPE VII GP Funds. GPE VII GP S.a.r.l. is the General Partner of the GPE VII GP S.a.r.l. Funds.

GPE VIII LLC is the General Partner of GPE VIII GP Limited Partnership (“GPE VIII GP”), GPE VIII GP S.a.r.l. (“GPE VIII GP S.a.r.l.”), and AP GPE VIII GP Limited Partnership (“AP GPE VIII GP”). GPE VIII GP S.a.r.l. is the General Partner of the GPE VIII GP S.a.r.l. Funds and of GPE VIII-C. GPE VIII GP is the General Partner of the GPE VIII GP Funds. AP GPE VIII GP is the General Partner of the Advent Partners GPE VIII Funds.

(4) Each of the entities named above are referred to herein as “Reporting Persons.” Each Reporting Person disclaims Section 16 beneficial ownership of the shares reported herein except to the extent of its respective pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or any other purpose.


Page 2 of 2

EX-99.2 3 brhc10017660_ex99-2.htm EXHIBIT 99.2

Exhibit 99.2

Joint Filer Information

Name of Joint Filer:
Double Eagle Investor Holdings, L.P.
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
December 3, 2020
Designated Filer:
Advent International Corporation

Signature:

DOUBLE EAGLE INVESTOR HOLDINGS, L.P.
By: Double Eagle GP, LLC, its General Partner
By: Advent International Corporation, its Sole Member

By:
/s/ Michael Ristaino
 
Name: Michael Ristaino
 
Title: Vice President of Finance - Fund Administration
 

December 7, 2020
Date
 
Page 1 of 48

Joint Filer Information

Name of Joint Filer:
Double Eagle GP, LLC
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
December 3, 2020
Designated Filer:
Advent International Corporation

Signature:

DOUBLE EAGLE GP, LLC
By: Advent International Corporation, its Sole Member

By:
/s/ Michael Ristaino
 
Name: Michael Ristaino
 
Title: Vice President of Finance - Fund Administration
 

December 7, 2020
Date
 
Page 2 of 48

Joint Filer Information
 
Name of Joint Filer:
Advent International GPE VIII-C Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
December 3, 2020
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-C LIMITED PARTNERSHIP
     
By: GPE VIII GP S.à r.l., its General Partner
     
By: Advent International GPE VIII, LLC, its Manager
 
/s/ Jarlyth Gibson
 
By: Advent International Corporation, its Manager
 
Jarlyth Gibson, Manager
 

By:
/s/ Michael Ristaino
 
Name: Michael Ristaino
 
Title: Vice President of Finance - Fund Administration
 

December 7, 2020
Date
 
Page 3 of 48

Joint Filer Information
 
Name of Joint Filer:
GPE VIII GP S.à r.l.
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
December 3, 2020
Designated Filer:
Advent International Corporation

Signature:

GPE VIII GP S.à r.l.
     
By: Advent International GPE VIII, LLC, its Manager
 
/s/ Jarlyth Gibson
 
By: Advent International Corporation, its Manager
 
Jarlyth Gibson, Manager
 

By:
/s/ Michael Ristaino
 
Name: Michael Ristaino
 
Title: Vice President of Finance - Fund Administration
 

December 7, 2020
Date

Page 4 of 48

Joint Filer Information
 
Name of Joint Filer:
GPE VIII GP Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
December 3, 2020
Designated Filer:
Advent International Corporation

Signature:

GPE VIII GP LIMITED PARTNERSHIP
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:
/s/ Michael Ristaino
 
Name: Michael Ristaino
 
Title: Vice President of Finance - Fund Administration
 

December 7, 2020
Date
 
Page 5 of 48

Joint Filer Information
 
Name of Joint Filer:
Advent International GPE VIII, LLC
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
December 3, 2020
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII, LLC
By: Advent International Corporation, its Manager

By:
/s/ Michael Ristaino
 
Name: Michael Ristaino
 
Title: Vice President of Finance - Fund Administration
 

December 7, 2020
Date
 
Page 6 of 48

Joint Filer Information
 
Name of Joint Filer:
GPE VII GP S.à r.l.
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
December 3, 2020
Designated Filer:
Advent International Corporation

Signature:

GPE VII GP S.à r.l.
     
By: Advent International GPE VIII, LLC, its Manager
 
/s/ Jarlyth Gibson
 
By: Advent International Corporation, its Manager
 
Jarlyth Gibson, Manager
 

By:
/s/ Michael Ristaino
 
Name: Michael Ristaino
 
Title: Vice President of Finance - Fund Administration
 

December 7, 2020
Date
 
Page 7 of 48

Joint Filer Information
 
Name of Joint Filer:
GPE VII GP Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
December 3, 2020
Designated Filer:
Advent International Corporation

Signature:

GPE VII GP LIMITED PARTNERSHIP
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:
/s/ Michael Ristaino
 
Name: Michael Ristaino
 
Title: Vice President of Finance - Fund Administration
 

December 7, 2020
Date
 
Page 8 of 48

Joint Filer Information
 
Name of Joint Filer:
Advent International GPE VII, LLC
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
December 3, 2020
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VII, LLC
By: Advent International Corporation, its Manager

By:
/s/ Michael Ristaino
 
Name: Michael Ristaino
 
Title: Vice President of Finance - Fund Administration
 

December 7, 2020
Date
 
Page 9 of 48

Joint Filer Information
 
Name of Joint Filer:
AP GPE VIII GP Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
December 3, 2020
Designated Filer:
Advent International Corporation

Signature:

AP GPE VIII GP LIMITED PARTNERSHIP
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:
/s/ Michael Ristaino
 
Name: Michael Ristaino
 
Title: Vice President of Finance - Fund Administration
 

December 7, 2020
Date
 
Page 10 of 48

Joint Filer Information
 
Name of Joint Filer:
Advent Partners GPE VIII Cayman Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
December 3, 2020
Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VIII CAYMAN LIMITED PARTNERSHIP
By: AP GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:
/s/ Michael Ristaino
 
Name: Michael Ristaino
 
Title: Vice President of Finance - Fund Administration
 

December 7, 2020
Date

Page 11 of 48

Joint Filer Information
 
Name of Joint Filer:
Advent Partners GPE VIII-B Cayman Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
December 3, 2020
Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VIII-B CAYMAN LIMITED PARTNERSHIP
By: AP GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:
/s/ Michael Ristaino
 
Name: Michael Ristaino
 
Title: Vice President of Finance - Fund Administration
 

December 7, 2020
Date
 
Page 12 of 48

Joint Filer Information
 
Name of Joint Filer:
Advent Partners GPE VIII Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
December 3, 2020
Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VIII LIMITED PARTNERSHIP
By: AP GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:
/s/ Michael Ristaino
 
Name: Michael Ristaino
 
Title: Vice President of Finance - Fund Administration
 

December 7, 2020
Date
 
Page 13 of 48

Joint Filer Information
 
Name of Joint Filer:
Advent Partners GPE VIII-A Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
December 3, 2020
Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VIII-A LIMITED PARTNERSHIP
By: AP GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:
/s/ Michael Ristaino
 
Name: Michael Ristaino
 
Title: Vice President of Finance - Fund Administration
 

December 7, 2020
Date
 
Page 14 of 48

Joint Filer Information
 
Name of Joint Filer:
Advent Partners GPE VIII-A Cayman Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
December 3, 2020
Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VIII-A CAYMAN LIMITED PARTNERSHIP
By: AP GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:
/s/ Michael Ristaino
 
Name: Michael Ristaino
 
Title: Vice President of Finance - Fund Administration
 

December 7, 2020
Date
 
Page 15 of 48

Joint Filer Information
 
Name of Joint Filer:
Advent International GPE VII-A Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
December 3, 2020
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VII-A LIMITED PARTNERSHIP
By: GPE VII GP Limited Partnership, its General Partner
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:
/s/ Michael Ristaino
 
Name: Michael Ristaino
 
Title: Vice President of Finance - Fund Administration
 

December 7, 2020
Date
 
Page 16 of 48

Joint Filer Information
 
Name of Joint Filer:
Advent International GPE VII-E Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
December 3, 2020
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VII-E LIMITED PARTNERSHIP
By: GPE VII GP Limited Partnership, its General Partner
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:
/s/ Michael Ristaino
 
Name: Michael Ristaino
 
Title: Vice President of Finance - Fund Administration
 

December 7, 2020
Date
 
Page 17 of 48

Joint Filer Information
 
Name of Joint Filer:
Advent International GPE VII-H Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
December 3, 2020
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VII-H LIMITED PARTNERSHIP
By: GPE VII GP Limited Partnership, its General Partner
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:
/s/ Michael Ristaino
 
Name: Michael Ristaino
 
Title: Vice President of Finance - Fund Administration
 

December 7, 2020
Date
 
Page 18 of 48

Joint Filer Information
 
Name of Joint Filer:
Advent Partners GPE VII Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
December 3, 2020
Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VII LIMITED PARTNERSHIP
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:
/s/ Michael Ristaino
 
Name: Michael Ristaino
 
Title: Vice President of Finance - Fund Administration
 

December 7, 2020
Date
 
Page 19 of 48

Joint Filer Information
 
Name of Joint Filer:
Advent Partners GPE VII 2014 Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
December 3, 2020
Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VII 2014 LIMITED PARTNERSHIP
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:
/s/ Michael Ristaino
 
Name: Michael Ristaino
 
Title: Vice President of Finance - Fund Administration
 

December 7, 2020
Date
 
Page 20 of 48

Joint Filer Information
 
Name of Joint Filer:
Advent Partners GPE VII-A Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
December 3, 2020
Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VII-A LIMITED PARTNERSHIP
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:
/s/ Michael Ristaino
 
Name: Michael Ristaino
 
Title: Vice President of Finance - Fund Administration
 

December 7, 2020
Date
 
Page 21 of 48

Joint Filer Information
 
Name of Joint Filer:
Advent Partners GPE VII-A 2014 Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
December 3, 2020
Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VII-A 2014 LIMITED PARTNERSHIP
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:
/s/ Michael Ristaino
 
Name: Michael Ristaino
 
Title: Vice President of Finance - Fund Administration
 

December 7, 2020
Date
 
Page 22 of 48

Joint Filer Information
 
Name of Joint Filer:
Advent Partners GPE VII Cayman Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
December 3, 2020
Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VII CAYMAN LIMITED PARTNERSHIP
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:
/s/ Michael Ristaino
 
Name: Michael Ristaino
 
Title: Vice President of Finance - Fund Administration
 

December 7, 2020
Date

Page 23 of 48

Joint Filer Information
 
Name of Joint Filer:
Advent Partners GPE VII 2014 Cayman Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
December 3, 2020
Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VII 2014 CAYMAN LIMITED PARTNERSHIP
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:
/s/ Michael Ristaino
 
Name: Michael Ristaino
 
Title: Vice President of Finance - Fund Administration
 

December 7, 2020
Date
 
Page 24 of 48

Joint Filer Information
 
Name of Joint Filer:
Advent Partners GPE VII-A Cayman Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
December 3, 2020
Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VII-A CAYMAN LIMITED PARTNERSHIP
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:
/s/ Michael Ristaino
 
Name: Michael Ristaino
 
Title: Vice President of Finance - Fund Administration
 

December 7, 2020
Date
 
Page 25 of 48

Joint Filer Information
 
Name of Joint Filer:
Advent Partners GPE VII-B Cayman Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
December 3, 2020
Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VII-B CAYMAN LIMITED PARTNERSHIP
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:
/s/ Michael Ristaino
 
Name: Michael Ristaino
 
Title: Vice President of Finance - Fund Administration
 

December 7, 2020
Date
 
Page 26 of 48

Joint Filer Information
 
Name of Joint Filer:
Advent Partners GPE VII-A 2014 Cayman Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
December 3, 2020
Designated Filer:
Advent International Corporation

Signature:

ADVENT PARTNERS GPE VII-A 2014 CAYMAN LIMITED PARTNERSHIP
By: Advent International GPE VII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:
/s/ Michael Ristaino
 
Name: Michael Ristaino
 
Title: Vice President of Finance - Fund Administration
 

December 7, 2020
Date
 
Page 27 of 48

Joint Filer Information
 
Name of Joint Filer:
Advent International GPE VIII Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
December 3, 2020
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VIII, LLC, its Manager
 
/s/ Jarlyth Gibson
 
By: Advent International Corporation, its Manager
 
Jarlyth Gibson, Manager
 

By:
/s/ Michael Ristaino
 
Name: Michael Ristaino
 
Title: Vice President of Finance - Fund Administration
 

December 7, 2020
Date
 
Page 28 of 48

Joint Filer Information
 
Name of Joint Filer:
Advent International GPE VIII-B Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
December 3, 2020
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-B LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VIII, LLC, its Manager
 
/s/ Jarlyth Gibson
 
By: Advent International Corporation, its Manager
 
Jarlyth Gibson, Manager
 

By:
/s/ Michael Ristaino
 
Name: Michael Ristaino
 
Title: Vice President of Finance - Fund Administration
 

December 7, 2020
Date
 
Page 29 of 48

Joint Filer Information
 
Name of Joint Filer:
Advent International GPE VIII-B-1 Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
December 3, 2020
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-B-1 LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VIII, LLC, its Manager
 
/s/ Jarlyth Gibson
 
By: Advent International Corporation, its Manager
 
Jarlyth Gibson, Manager
 

By:
/s/ Michael Ristaino
 
Name: Michael Ristaino
 
Title: Vice President of Finance - Fund Administration
 

December 7, 2020
Date
 
Page 30 of 48

Joint Filer Information
 
Name of Joint Filer:
Advent International GPE VIII-B-2 Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
December 3, 2020
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-B-2 LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VIII, LLC, its Manager
 
/s/ Jarlyth Gibson
 
By: Advent International Corporation, its Manager
 
Jarlyth Gibson, Manager
 

By:
/s/ Michael Ristaino
 
Name: Michael Ristaino
 
Title: Vice President of Finance - Fund Administration
 

December 7, 2020
Date
 
Page 31 of 48

Joint Filer Information
 
Name of Joint Filer:
Advent International GPE VIII-B-3 Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
December 3, 2020
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-B-3 LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VIII, LLC, its Manager
 
/s/ Jarlyth Gibson
 
By: Advent International Corporation, its Manager
 
Jarlyth Gibson, Manager
 

By:
/s/ Michael Ristaino
 
Name: Michael Ristaino
 
Title: Vice President of Finance - Fund Administration
 

December 7, 2020
Date
 
Page 32 of 48

Joint Filer Information
 
Name of Joint Filer:
Advent International GPE VIII-D Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
December 3, 2020
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-D LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VIII, LLC, its Manager
 
/s/ Jarlyth Gibson
 
By: Advent International Corporation, its Manager
 
Jarlyth Gibson, Manager
 

By:
/s/ Michael Ristaino
 
Name: Michael Ristaino
 
Title: Vice President of Finance - Fund Administration
 

December 7, 2020
Date
 
Page 33 of 48

Joint Filer Information
 
Name of Joint Filer:
Advent International GPE VIII-F Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
December 3, 2020
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-F LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VIII, LLC, its Manager
 
/s/ Jarlyth Gibson
 
By: Advent International Corporation, its Manager
 
Jarlyth Gibson, Manager
 

By:
/s/ Michael Ristaino
 
Name: Michael Ristaino
 
Title: Vice President of Finance - Fund Administration
 

December 7, 2020
Date
 
Page 34 of 48

Joint Filer Information
 
Name of Joint Filer:
Advent International GPE VIII-H Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
December 3, 2020
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-H LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VIII, LLC, its Manager
 
/s/ Jarlyth Gibson
 
By: Advent International Corporation, its Manager
 
Jarlyth Gibson, Manager
 

By:
/s/ Michael Ristaino
 
Name: Michael Ristaino
 
Title: Vice President of Finance - Fund Administration
 

December 7, 2020
Date
 
Page 35 of 48

Joint Filer Information
 
Name of Joint Filer:
Advent International GPE VIII-I Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
December 3, 2020
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-I LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VIII, LLC, its Manager
 
/s/ Jarlyth Gibson
 
By: Advent International Corporation, its Manager
 
Jarlyth Gibson, Manager
 

By:
/s/ Michael Ristaino
 
Name: Michael Ristaino
 
Title: Vice President of Finance - Fund Administration
 

December 7, 2020
Date
 
Page 36 of 48

Joint Filer Information
 
Name of Joint Filer:
Advent International GPE VIII-J Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
December 3, 2020
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-J LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VIII, LLC, its Manager
 
/s/ Jarlyth Gibson
 
By: Advent International Corporation, its Manager
 
Jarlyth Gibson, Manager
 

By:
/s/ Michael Ristaino
 
Name: Michael Ristaino
 
Title: Vice President of Finance - Fund Administration
 

December 7, 2020
Date
 
Page 37 of 48

Joint Filer Information
 
Name of Joint Filer:
Advent International GPE VIII-A Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
December 3, 2020
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-A LIMITED PARTNERSHIP
By: GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:
/s/ Michael Ristaino
 
Name: Michael Ristaino
 
Title: Vice President of Finance - Fund Administration
 

December 7, 2020
Date
 
Page 38 of 48

Joint Filer Information
 
Name of Joint Filer:
Advent International GPE VIII-E Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
December 3, 2020
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-E LIMITED PARTNERSHIP
By: GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:
/s/ Michael Ristaino
 
Name: Michael Ristaino
 
Title: Vice President of Finance - Fund Administration
 

December 7, 2020
Date
 
Page 39 of 48

Joint Filer Information
 
Name of Joint Filer:
Advent International GPE VIII-G Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
December 3, 2020
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-G LIMITED PARTNERSHIP
By: GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:
/s/ Michael Ristaino
 
Name: Michael Ristaino
 
Title: Vice President of Finance - Fund Administration
 

December 7, 2020
Date
 
Page 40 of 48

Joint Filer Information
 
Name of Joint Filer:
Advent International GPE VIII-K Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
December 3, 2020
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-K LIMITED PARTNERSHIP
By: GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:
/s/ Michael Ristaino
 
Name: Michael Ristaino
 
Title: Vice President of Finance - Fund Administration
 

December 7, 2020
Date
 
Page 41 of 48

Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII-L Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
December 3, 2020
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-L LIMITED PARTNERSHIP
By: GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:
/s/ Michael Ristaino
 
Name: Michael Ristaino
 
Title: Vice President of Finance - Fund Administration
 

December 7, 2020
Date
 
Page 42 of 48

Joint Filer Information
 
Name of Joint Filer:
Advent International GPE VII Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
December 3, 2020
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VII LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VII, LLC, its Manager
 
/s/ Jarlyth Gibson
 
By: Advent International Corporation, its Manager
 
Jarlyth Gibson, Manager
 

By:
/s/ Michael Ristaino
 
Name: Michael Ristaino
 
Title: Vice President of Finance - Fund Administration
 

December 7, 2020
Date
 
Page 43 of 48

Joint Filer Information
 
Name of Joint Filer:
Advent International GPE VII-B Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
December 3, 2020
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VII-B LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VII, LLC, its Manager
 
/s/ Jarlyth Gibson
 
By: Advent International Corporation, its Manager
 
Jarlyth Gibson, Manager
 

By:
/s/ Michael Ristaino
 
Name: Michael Ristaino
 
Title: Vice President of Finance - Fund Administration
 

December 7, 2020
Date
 
Page 44 of 48

Joint Filer Information
 
Name of Joint Filer:
Advent International GPE VII-C Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
December 3, 2020
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VII-C LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VII, LLC, its Manager
 
/s/ Jarlyth Gibson
 
By: Advent International Corporation, its Manager
 
Jarlyth Gibson, Manager
 

By:
/s/ Michael Ristaino
 
Name: Michael Ristaino
 
Title: Vice President of Finance - Fund Administration
 

December 7, 2020
Date
 
Page 45 of 48

Joint Filer Information
 
Name of Joint Filer:
Advent International GPE VII-D Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
December 3, 2020
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VII-D LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VII, LLC, its Manager
 
/s/ Jarlyth Gibson
 
By: Advent International Corporation, its Manager
 
Jarlyth Gibson, Manager
 

By:
/s/ Michael Ristaino
 
Name: Michael Ristaino
 
Title: Vice President of Finance - Fund Administration
 

December 7, 2020
Date
 
Page 46 of 48

Joint Filer Information
 
Name of Joint Filer:
Advent International GPE VII-F Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
December 3, 2020
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VII-F LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VII, LLC, its Manager
 
/s/ Jarlyth Gibson
 
By: Advent International Corporation, its Manager
 
Jarlyth Gibson, Manager
 

By:
/s/ Michael Ristaino
 
Name: Michael Ristaino
 
Title: Vice President of Finance - Fund Administration
 

December 7, 2020
Date
 
Page 47 of 48

Joint Filer Information
 
Name of Joint Filer:
Advent International GPE VII-G Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
to be Reported (Month/Day/Year):
December 3, 2020
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VII-G LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VII, LLC, its Manager
 
/s/ Jarlyth Gibson
 
By: Advent International Corporation, its Manager
 
Jarlyth Gibson, Manager
 

By:
/s/ Michael Ristaino
 
Name: Michael Ristaino
 
Title: Vice President of Finance - Fund Administration
 

December 7, 2020
Date


Page 48 of 48